<?xml version="1.0" encoding="UTF-8"?>
<data xmlns="http://www.aopkb.org/aop-xml">
  <stressor id="c8451ad9-a595-4d9a-9130-4403d1ce104e">
    <name>All-trans retinoic acid</name>
    <description></description>
    <exposure-characterization></exposure-characterization>
    <creation-timestamp>2022-02-15T10:43:46</creation-timestamp>
    <last-modification-timestamp>2022-02-15T10:43:46</last-modification-timestamp>
  </stressor>
  <key-event id="b49068a8-a4f9-4890-a10d-9921767e2f83">
    <title>Inhibition, TBX1</title>
    <short-name>Inhibition, TBX1</short-name>
    <biological-organization-level>Molecular</biological-organization-level>
    <description></description>
    <measurement-methodology></measurement-methodology>
    <evidence-supporting-taxonomic-applicability></evidence-supporting-taxonomic-applicability>
    <applicability>
    </applicability>
    <references></references>
    <source>AOPWiki</source>
    <creation-timestamp>2019-08-13T00:34:07</creation-timestamp>
    <last-modification-timestamp>2019-08-13T00:34:07</last-modification-timestamp>
  </key-event>
  <key-event id="e7f98911-6a00-4217-afc1-240e46305983">
    <title>Disruption, Neural crest cell migration</title>
    <short-name>Disruption, Neural crest cell migration</short-name>
    <biological-organization-level>Cellular</biological-organization-level>
    <description></description>
    <measurement-methodology></measurement-methodology>
    <evidence-supporting-taxonomic-applicability></evidence-supporting-taxonomic-applicability>
    <applicability>
    </applicability>
    <references></references>
    <source>AOPWiki</source>
    <creation-timestamp>2019-08-13T00:50:35</creation-timestamp>
    <last-modification-timestamp>2019-08-13T00:50:35</last-modification-timestamp>
  </key-event>
  <key-event id="54f4b518-f431-4fca-b4c0-07cb4a396233">
    <title>Disruption, Progenitor cells of second heart field</title>
    <short-name>Disruption, Progenitor cells of second heart field</short-name>
    <biological-organization-level>Cellular</biological-organization-level>
    <description>&lt;p&gt;&lt;span style="font-size:11pt"&gt;&lt;span style="font-family:&amp;quot;Calibri Light&amp;quot;,sans-serif"&gt;&lt;span style="color:black"&gt;The first heart field (FHF) and second heart field (SHF) can be distinguished in the cardiac crescent and reside in a horseshoe shaped form (Brade et al., 2018). The SHF cells will stay in a proliferative state until they enter the heart tube to differentiate (Brade et al., 2018). The SHF promotes heart tube elongation at the venous and arterial poles and contributes to the sub pulmonary myocardium &lt;/span&gt;(el Robrini et al., 2016; S. Wang &amp;amp; Moise, 2019)&lt;span style="color:black"&gt;. The SHF will contribute to the right ventricle and outflow tract (Carlson, 2018).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style="font-size:11pt"&gt;&lt;span style="font-family:&amp;quot;Calibri Light&amp;quot;,sans-serif"&gt;The SHF progenitors facilitate development of the outflow tract, atrium and right ventricle (S. Wang &amp;amp; Moise, 2019). The SHF contributes to the distal myocardium of the OFT and the mesodermal part of great vessel smooth muscles (Buckingham et al., 2005; Choudhary et al., 2009; Dyer &amp;amp; Kirby, 2009). The anterior heart field (AHF) within the SHF gives rise to the OFT and the right ventricle &lt;span style="color:black"&gt;(Kelly et al., 2001; Meilhac et al., 2004; Zaffran et al., 2004). Mef2c positive cells are specific to the AHF (Dodou et al., 2004; Verzi et al., 2005). The AHF requires hedgehog (Hh) signaling from the pharyngeal endoderm for OFT septation but not for OFT elongation (Goddeeris et al., 2007).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</description>
    <measurement-methodology></measurement-methodology>
    <evidence-supporting-taxonomic-applicability></evidence-supporting-taxonomic-applicability>
    <applicability>
    </applicability>
    <references>&lt;p&gt;&lt;span style="font-size:11pt"&gt;&lt;span style="font-family:&amp;quot;Calibri Light&amp;quot;,sans-serif"&gt;Brade, T., Pane, L. S., Moretti, A., Chien, K. R., &amp;amp; Laugwitz, K.-L. (2018). &lt;em&gt;Embryonic Heart Progenitors and Cardiogenesis&lt;/em&gt;. 1&amp;ndash;18. https://doi.org/10.1101/cshperspect.a013847&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style="font-size:11pt"&gt;&lt;span style="font-family:&amp;quot;Calibri Light&amp;quot;,sans-serif"&gt;Buckingham, M., Meilhac, S., &amp;amp; Zaffran, S. (2005). Building the mammalian heart from two sources of myocardial cells. &lt;em&gt;Nature Reviews. Genetics&lt;/em&gt;, &lt;em&gt;6&lt;/em&gt;(11), 826&amp;ndash;835. https://doi.org/10.1038/NRG1710&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style="font-size:11pt"&gt;&lt;span style="font-family:&amp;quot;Calibri Light&amp;quot;,sans-serif"&gt;Carlson, B. M. (2018). &lt;em&gt;Human Embryology and Developmental biology E-book&lt;/em&gt;. https://books.google.com/books?hl=nl&amp;amp;lr=&amp;amp;id=iyx6DwAAQBAJ&amp;amp;oi=fnd&amp;amp;pg=PP1&amp;amp;dq=carlson+human+embryology&amp;amp;ots=ZCgJJZr-17&amp;amp;sig=LXSoOfaYSNJLoFYaiiJHeqrNyw4&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style="font-size:11pt"&gt;&lt;span style="font-family:&amp;quot;Calibri Light&amp;quot;,sans-serif"&gt;Choudhary, B., Zhou, J., Li, P., Thomas, S., Kaartinen, V., &amp;amp; Sucov, H. M. (2009). Absence of TGFbeta signaling in embryonic vascular smooth muscle leads to reduced lysyl oxidase expression, impaired elastogenesis, and aneurysm. &lt;em&gt;Genesis (New York, N.Y. : 2000)&lt;/em&gt;, &lt;em&gt;47&lt;/em&gt;(2), 115&amp;ndash;121. https://doi.org/10.1002/DVG.20466&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style="font-size:11pt"&gt;&lt;span style="font-family:&amp;quot;Calibri Light&amp;quot;,sans-serif"&gt;Dodou, E., Verzi, M. P., Anderson, J. P., Xu, S. M., &amp;amp; Black, B. L. (2004). Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. &lt;em&gt;Development (Cambridge, England)&lt;/em&gt;, &lt;em&gt;131&lt;/em&gt;(16), 3931&amp;ndash;3942. https://doi.org/10.1242/DEV.01256&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style="font-size:11pt"&gt;&lt;span style="font-family:&amp;quot;Calibri Light&amp;quot;,sans-serif"&gt;Dyer, L. A., &amp;amp; Kirby, M. L. (2009). The role of secondary heart field in cardiac development. &lt;em&gt;Developmental Biology&lt;/em&gt;, &lt;em&gt;336&lt;/em&gt;(2), 137&amp;ndash;144. https://doi.org/10.1016/J.YDBIO.2009.10.009&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style="font-size:11pt"&gt;&lt;span style="font-family:&amp;quot;Calibri Light&amp;quot;,sans-serif"&gt;el Robrini, N., Etchevers, H. C., Ryckeb&amp;uuml;sch, L., Faure, E., Eudes, N., Niederreither, K., Zaffran, S., &amp;amp; Bertrand, N. (2016). Cardiac outflow morphogenesis depends on effects of retinoic acid signaling on multiple cell lineages. &lt;em&gt;Developmental Dynamics&lt;/em&gt;, &lt;em&gt;245&lt;/em&gt;(3), 388&amp;ndash;401. https://doi.org/10.1002/dvdy.24357&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style="font-size:11pt"&gt;&lt;span style="font-family:&amp;quot;Calibri Light&amp;quot;,sans-serif"&gt;Goddeeris, M. M., Schwartz, R., Klingensmith, J., &amp;amp; Meyers, E. N. (2007). Independent requirements for Hedgehog signaling by both the anterior heart field and neural crest cells for outflow tract development. &lt;em&gt;Development (Cambridge, England)&lt;/em&gt;, &lt;em&gt;134&lt;/em&gt;(8), 1593&amp;ndash;1604. https://doi.org/10.1242/DEV.02824&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style="font-size:11pt"&gt;&lt;span style="font-family:&amp;quot;Calibri Light&amp;quot;,sans-serif"&gt;Kelly, R. G., Brown, N. A., &amp;amp; Buckingham, M. E. (2001). The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. &lt;em&gt;Developmental Cell&lt;/em&gt;, &lt;em&gt;1&lt;/em&gt;(3), 435&amp;ndash;440. https://doi.org/10.1016/S1534-5807(01)00040-5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style="font-size:11pt"&gt;&lt;span style="font-family:&amp;quot;Calibri Light&amp;quot;,sans-serif"&gt;Meilhac, S. M., Esner, M., Kelly, R. G., Nicolas, J. F., &amp;amp; Buckingham, M. E. (2004). The clonal origin of myocardial cells in different regions of the embryonic mouse heart. &lt;em&gt;Developmental Cell&lt;/em&gt;, &lt;em&gt;6&lt;/em&gt;(5), 685&amp;ndash;698. https://doi.org/10.1016/S1534-5807(04)00133-9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style="font-size:11pt"&gt;&lt;span style="font-family:&amp;quot;Calibri Light&amp;quot;,sans-serif"&gt;Verzi, M. P., McCulley, D. J., de Val, S., Dodou, E., &amp;amp; Black, B. L. (2005). The right ventricle, outflow tract, and ventricular septum comprise a restricted expression domain within the secondary/anterior heart field. &lt;em&gt;Developmental Biology&lt;/em&gt;, &lt;em&gt;287&lt;/em&gt;(1), 134&amp;ndash;145. https://doi.org/10.1016/J.YDBIO.2005.08.041&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style="font-size:11pt"&gt;&lt;span style="font-family:&amp;quot;Calibri Light&amp;quot;,sans-serif"&gt;Wang, S., &amp;amp; Moise, A. R. (2019). Recent insights on the role and regulation of retinoic acid signaling during epicardial development. &lt;em&gt;Genesis&lt;/em&gt;, &lt;em&gt;57&lt;/em&gt;(7). https://doi.org/10.1002/dvg.23303&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style="font-size:11pt"&gt;&lt;span style="font-family:&amp;quot;Calibri Light&amp;quot;,sans-serif"&gt;Zaffran, S., Kelly, R. G., Meilhac, S. M., Buckingham, M. E., &amp;amp; Brown, N. A. (2004). Right ventricular myocardium derives from the anterior heart field. &lt;em&gt;Circulation Research&lt;/em&gt;, &lt;em&gt;95&lt;/em&gt;(3), 261&amp;ndash;268. https://doi.org/10.1161/01.RES.0000136815.73623.BE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</references>
    <source>AOPWiki</source>
    <creation-timestamp>2019-08-13T00:51:42</creation-timestamp>
    <last-modification-timestamp>2022-02-15T10:39:17</last-modification-timestamp>
  </key-event>
  <key-event id="d44b0f99-722a-40e0-8de8-dda2b267ba95">
    <title>Impairment, Fourth pharyngeal arch development</title>
    <short-name>Impairment, Fourth pharyngeal arch development</short-name>
    <biological-organization-level>Tissue</biological-organization-level>
    <description></description>
    <measurement-methodology></measurement-methodology>
    <evidence-supporting-taxonomic-applicability></evidence-supporting-taxonomic-applicability>
    <applicability>
    </applicability>
    <references></references>
    <source>AOPWiki</source>
    <creation-timestamp>2019-08-13T00:53:35</creation-timestamp>
    <last-modification-timestamp>2019-08-13T00:53:35</last-modification-timestamp>
  </key-event>
  <key-event id="5574599d-7d2c-4fcd-9464-a1acda37215f">
    <title>Abnormalities, Cardiac outflow tract formation</title>
    <short-name>Abnormalities, Cardiac outflow tract formation</short-name>
    <biological-organization-level>Organ</biological-organization-level>
    <description></description>
    <measurement-methodology></measurement-methodology>
    <evidence-supporting-taxonomic-applicability></evidence-supporting-taxonomic-applicability>
    <applicability>
    </applicability>
    <references></references>
    <source>AOPWiki</source>
    <creation-timestamp>2019-08-13T00:54:34</creation-timestamp>
    <last-modification-timestamp>2019-08-13T00:54:34</last-modification-timestamp>
  </key-event>
  <key-event id="44b4c310-d4b7-434a-b35e-36cf7a779b19">
    <title>Anomalies, Congenital cardiac conotruncal</title>
    <short-name>Anomalies, Congenital cardiac conotruncal</short-name>
    <biological-organization-level>Individual</biological-organization-level>
    <description></description>
    <measurement-methodology></measurement-methodology>
    <evidence-supporting-taxonomic-applicability></evidence-supporting-taxonomic-applicability>
    <applicability>
    </applicability>
    <references></references>
    <source>AOPWiki</source>
    <creation-timestamp>2019-08-13T00:56:30</creation-timestamp>
    <last-modification-timestamp>2019-08-13T00:56:30</last-modification-timestamp>
  </key-event>
  <aop id="7fb7197e-8f95-4252-b3b1-bb82ac23db35">
    <title>TBX1 inhibition leading to congenital cardiac conotruncal anomalies</title>
    <short-name>TBX1 inhibition leading to congenital cardiac conotruncal anomalies</short-name>
    <point-of-contact>Agnes Aggy</point-of-contact>
    <authors>&lt;p&gt;&lt;span style="font-size:14px"&gt;&lt;span style="font-family:times new roman,times,serif"&gt;Jinsoo Lee, Korea Institute of Toxicology&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style="font-size:14px"&gt;Wook-Joon Yu,&amp;nbsp;&lt;/span&gt;&lt;span style="font-size:14px"&gt;&lt;span style="font-family:times new roman,times,serif"&gt;Korea Institute of Toxicology&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style="font-size:14px"&gt;&lt;span style="font-family:times new roman,times,serif"&gt;Ji-Seong Jeong,&amp;nbsp;Korea Institute of Toxicology&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style="font-size:14px"&gt;&lt;span style="font-family:times new roman,times,serif"&gt;Jung-Hwa Oh,&amp;nbsp;Korea Institute of Toxicology&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</authors>
    <coaches>
    </coaches>
    <external_links>
    </external_links>
    <status>
      <wiki-license>All rights reserved</wiki-license>
    </status>
    <oecd-project></oecd-project>
    <handbook-version>2.0</handbook-version>
    <abstract></abstract>
    <molecular-initiating-event key-event-id="b49068a8-a4f9-4890-a10d-9921767e2f83">
      <evidence-supporting-chemical-initiation></evidence-supporting-chemical-initiation>
    </molecular-initiating-event>
    <key-events>
      <key-event key-event-id="e7f98911-6a00-4217-afc1-240e46305983"/>
      <key-event key-event-id="54f4b518-f431-4fca-b4c0-07cb4a396233"/>
      <key-event key-event-id="d44b0f99-722a-40e0-8de8-dda2b267ba95"/>
      <key-event key-event-id="5574599d-7d2c-4fcd-9464-a1acda37215f"/>
    </key-events>
    <adverse-outcome key-event-id="44b4c310-d4b7-434a-b35e-36cf7a779b19">
      <examples/>
    </adverse-outcome>
    <applicability>
    </applicability>
    <overall-assessment>
      <description></description>
      <applicability></applicability>
      <key-event-essentiality-summary></key-event-essentiality-summary>
      <weight-of-evidence-summary></weight-of-evidence-summary>
      <known-modulating-factors/>
      <quantitative-considerations></quantitative-considerations>
    </overall-assessment>
    <potential-applications></potential-applications>
    <references></references>
    <source>AOPWiki</source>
    <creation-timestamp>2019-08-06T03:03:26</creation-timestamp>
    <last-modification-timestamp>2023-09-25T16:27:00</last-modification-timestamp>
  </aop>
  <vendor-specific id="27e1484c-8314-4c21-8855-a87d58025923" name="AopWiki" version="2026-04-04 02:26:06 +0000">
    <stressor-reference id="c8451ad9-a595-4d9a-9130-4403d1ce104e" aop-wiki-id="725"/>
    <key-event-reference id="b49068a8-a4f9-4890-a10d-9921767e2f83" aop-wiki-id="1680"/>
    <key-event-reference id="e7f98911-6a00-4217-afc1-240e46305983" aop-wiki-id="1681"/>
    <key-event-reference id="54f4b518-f431-4fca-b4c0-07cb4a396233" aop-wiki-id="1682"/>
    <key-event-reference id="d44b0f99-722a-40e0-8de8-dda2b267ba95" aop-wiki-id="1683"/>
    <key-event-reference id="5574599d-7d2c-4fcd-9464-a1acda37215f" aop-wiki-id="1684"/>
    <key-event-reference id="44b4c310-d4b7-434a-b35e-36cf7a779b19" aop-wiki-id="1685"/>
    <aop-reference id="7fb7197e-8f95-4252-b3b1-bb82ac23db35" aop-wiki-id="304"/>
  </vendor-specific>
</data>
